UCB Announces Positive Phase 3 Studies for Bimekizumab in Hidradenitis Suppurativa ...Middle East

Top-line results show that the two Phase 3 studies, BE HEARD I and BE HEARD II, met their primary and key secondary endpoints with statistical significance and consistent clinical relevance First Phase 3 evidence to suggest that targeting IL-17F in addition to IL-17A may be a promising...

Hence then, the article about ucb announces positive phase 3 studies for bimekizumab in hidradenitis suppurativa was published today ( Friday 09/12/2022 - 03:08 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( UCB Announces Positive Phase 3 Studies for Bimekizumab in Hidradenitis Suppurativa )

Also on site :

• France to ditch American video conferencing services
• EU’s Kallas privately complaining about ‘dictator’ von der Leyen – Politico
• This Las Vegas Attraction Is Part Art Space, Part Theme Park—And It’s Expanding in 2026